Optimale Diagnostik und Therapie der mikrovaskulären Angina pectoris

 

 Buy Article Permissions and Reprints

Abstract

Patients with microvascular angina are characterized by angina pectoris with proof of myocardial ischemia in the absence of any relevant epicardial stenosis and without myocardial disease (type 1 coronary microvascular dysfunction according to Crea and Camici). Structural and functional alterations of the coronary microvessels (diameter < 500 µm) are the reason for this phenomenon. Frequently such alterations are associated with cardiovascular risk factors. Patients with angina pectoris without epicardial stenoses represent for 10 – 50 % of all patients undergoing coronary angiography depending on the clinical presentation. Diagnostic approaches include non-invasive (e. g. combination of coronary CT-angiography and positron emission tomography/echo Doppler-based coronary flow reserve measurements) as well as invasive procedures (coronary flow reserve measurements in response to adenosine, intracoronary acetylcholine testing). Pharmacological treatment of these patients is often challenging and should be based on the characterization of the underlying mechanisms. Moreover, strict risk factor control and individually titrated combinations of antianginal substances (e. g. beta blockers, calcium channel blockers, nitrates, ranolazine, ivabradine etc.) are recommended.

• Literatur

• 1 Hochman JS, Tamis JE, Thompson TD. et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. N Engl J Med 1999; 341: 226-232
  CrossrefPubMedGoogle Scholar
• 2 Patel MR, Peterson ED, Dai D. et al. Low diagnostic yield of elective coronary angiography. N Engl J Med 2010; 362: 886-895
  CrossrefPubMedGoogle Scholar
• 3 AQUA-Institut für angewandte Qualitätsförderung und Forschung im Gesundheitswesen GmbH. Bundesauswertung zum Erfassungsjahr 2014. 21/3 Koronarangiografie und perkutane Koronarintervention (PCI) 2015. https://sqg.de/downloads/Bundesauswertungen/2014/bu_Gesamt_21N3-KORO-PCI_2014.pdf Stand: 15.04.2017
  PubMedGoogle Scholar
• 4 Reis SE, Holubkov R, Conrad SmithAJ. et al. WISE Investigators. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J 2001; 141: 735-741
  CrossrefPubMedGoogle Scholar
• 5 Ong P, Athanasiadis A, Borgulya G. et al. High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). J Am Coll Cardiol 2012; 59: 655-662
  CrossrefPubMedGoogle Scholar
• 6 Kaski JC, Rosano GMC, Collins P. et al. Cardiac syndrome X: clinical characteristics and left ventricular function: long-term follow-up study. J Am Coll Cardiol 1995; 25: 807-814
  CrossrefPubMedGoogle Scholar
• 7 Crea F, Bairey MerzCN, Beltrame JF. et al. Coronary Vasomotion Disorders International Study Group (COVADIS). The parallel tales of microvascular angina and heart failure with preserved ejection fraction: a paradigm shift. Eur Heart J 2017; 38: 473-477
  PubMedGoogle Scholar
• 8 Agewall S, Beltrame JF, Reynolds HR. et al. WG on Cardiovascular Pharmacotherapy. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J 2017; 38: 143-153
  PubMedGoogle Scholar
• 9 Murthy VL, Naya M, Taqueti VR. et al. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation 2014; 129: 2518-2527
  CrossrefPubMedGoogle Scholar
• 10 Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007; 356: 830-840
  CrossrefPubMedGoogle Scholar
• 11 Rosano GM, Collins P, Kaski JC. et al. Syndrome X in women is associated with oestrogen deficiency. Eur Heart J 1995; 16: 610-614
  CrossrefPubMedGoogle Scholar
• 12 Fedele F, Mancone M, Chilian WM. et al. Role of genetic polymorphisms of ion channels in the pathophysiology of coronary microvascular dysfunction and ischemic heart disease. Basic Res Cardiol 2013; 108: 387
  CrossrefPubMedGoogle Scholar
• 13 Suzuki H, Takeyama Y, Koba S. et al. Small vessel pathology and coronary hemodynamics in patients with microvascular angina. Int J Cardiol 1994; 43: 139-150
  CrossrefPubMedGoogle Scholar
• 14 Steg PG, James SK, Atar D. et al. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569-2619
  CrossrefPubMedGoogle Scholar
• 15 Roffi M, Patrono C, Collet JP. et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016; 37: 267-315
  CrossrefPubMedGoogle Scholar
• 16 Pirozzolo G, Gabriele L, Athanasiadis A. et al. Functional coronary vasomotor abnormalities are frequent in patients with non-ST-segment elevation myocardial infarction without culprit lesion assessed by intracoronary acetylcholine testing. Clin Res Cardiol 2016; 105 (Suppl. 01) V11 doi:10.1007/s00392–016–0967-z
  PubMedGoogle Scholar
• 17 Galiuto L, De Caterina AR, Porfidia A. et al. Reversible coronary microvascular dysfunction: a common pathogenetic mechanism in Apical Ballooning or Tako-Tsubo Syndrome. Eur Heart J 2010; 31: 1319-1327
  CrossrefPubMedGoogle Scholar
• 18 Montalescot G, Sechtem U, Achenbach S. et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013; 34: 2949-3003
  CrossrefPubMedGoogle Scholar
• 19 Kajander S, Joutsiniemi E, Saraste M. et al. Cardiac positron emission tomography/computed tomography imaging accurately detects anatomically and functionally significant coronary artery disease. Circulation 2010; 122: 603-613
  CrossrefPubMedGoogle Scholar
• 20 White CW, Wright CB, Doty DB. et al. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis?. N Engl J Med 1984; 310: 819-824
  CrossrefPubMedGoogle Scholar
• 21 Ong P, Athanasiadis A, Borgulya G. et al. Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries. Circulation 2014; 129: 1723-1730
  CrossrefPubMedGoogle Scholar
• 22 Noto TJ Jr, Johnson LW, Krone R. et al. Cardiac catheterization 1990: a report of the Registry of the Society for Cardiac Angiography and Interventions (SCA&I). Cathet Cardiovasc Diagn 1991; 24: 75-83
  CrossrefPubMedGoogle Scholar
• 23 Taqueti VR, Shaw LJ, Cook NR. et al. Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography is Associated with Severely Impaired Coronary Flow Reserve, not Obstructive Disease. Circulation 2016; 135 (06) 566-577 doi: 10.1161/ CIRCULATIONAHA.116.023266
  PubMedGoogle Scholar
• 24 Pauly DF, Johnson BD, Anderson RD. et al. In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE). Am Heart J 2011; 162: 678-684
  CrossrefPubMedGoogle Scholar
• 25 Kayikcioglu M, Payzin S, Yavuzgil O. et al. Benefits of statin treatment in cardiac syndrome-X1. Eur Heart J 2003; 24: 1999-2005
  CrossrefPubMedGoogle Scholar
• 26 Sen N, Tavil Y, Erdamar H. et al. Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X. Anadolu Kardiyol Derg 2009; 9: 371-379
  PubMedGoogle Scholar
• 27 Russo G, Di Franco A, Lamendola P. et al. Lack of effect of nitrates on exercise stress test results in patients with microvascular angina. Cardiovasc Drugs Ther 2013; 27: 229-234
  CrossrefPubMedGoogle Scholar
• 28 Mehta PK, Goykhman P, Thomson LE. et al. Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease. JACC Cardiovasc Imaging 2011; 4: 514-522
  PubMedGoogle Scholar
• 29 Bairey MerzCN, Handberg EM, Shufelt CL. et al. A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve. Eur Heart J 2016; 37: 1504-1513
  CrossrefPubMedGoogle Scholar
• 30 Villano A, Di Franco A, Nerla R. et al. Effects of ivabradine and ranolazine in patients with microvascular angina pectoris. Am J Cardiol 2013; 112: 8-13
  CrossrefPubMedGoogle Scholar
• 31 Cannon RO, Quyyumi AA, Mincemoyer R. et al. Imipramine in Patients with Chest Pain Despite Normal Coronary Angiograms. N Engl J Med 1994; 330: 1411-1417
  CrossrefPubMedGoogle Scholar
• 32 Tyni-Lenne R, Stryjan S, Eriksson B. et al. Beneficial therapeutic effects of physical training and relaxation therapy in women with coronary syndrome X. Physiother Res Int 2002; 7: 35-43
  CrossrefPubMedGoogle Scholar
• 33 Johnson BD, Shaw LJ, Pepine CJ. et al. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study. Eur Heart J 2006; 27: 1408-1415
  PubMedGoogle Scholar
• 34 Lanza GA, Barone L, Di Monaco A. Effect of spinal cord stimulation in patients with refractory angina: evidence from observational studies. Neuromodulation 2012; 15: 542-549
  CrossrefPubMedGoogle Scholar